Skip to content
HomeJohnson & Johnson Statement on Collaboration with Merck

Johnson & Johnson Statement on Collaboration with Merck

Share Article
share to

New Brunswick, NJ (March 2, 2021) - We are pleased to collaborate with Merck as part of our global network to manufacture our COVID-19 vaccine. Merck has a long history of vaccine expertise, and we expect this manufacturing arrangement will enhance our production capacity so that we can supply beyond our current commitments.

Since January of 2020, we have been working directly with governments, health authorities and other companies to help end this pandemic. Merck is the ninth manufacturer to join our global network and this significant collaboration will further enable us to deliver our COVID-19 vaccine worldwide. We will continue to invest in collaborations so we can bring our full resources and best scientific minds to combat this pandemic.

You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.